(Q43894350)

English

A double-blind placebo-controlled randomized phase III trial of 5-fluorouracil and leucovorin, plus or minus trimetrexate, in previously untreated patients with advanced colorectal cancer

scientific article published in January 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

A double-blind placebo-controlled randomized phase III trial of 5-fluorouracil and leucovorin, plus or minus trimetrexate, in previously untreated patients with advanced colorectal cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

phase III clinical trial

0 references

colorectal cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

C D Blanke

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

J Shultz

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

J Cox

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

M Modiano

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

R Isaacs

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

B Kasimis

6

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

R Schilsky

7

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

J Fleagle

8

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

M Moore

9

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

N Kemeny

10

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

D Carlin

11

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

L Hammershaimb

12

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

D Haller

13

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

publication date

1 January 2002

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

number of pages

5

1 reference

based on heuristic

inferred from page(s)

Annals of Oncology

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

87-91

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Cancer statistics, 1996.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF043

21 January 2018

Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF043

21 January 2018

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF043

21 January 2018

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF043

21 January 2018

Biochemical pharmacology of the lipophilic antifolate, trimetrexate

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF043

21 January 2018

Uptake and efficacy of trimetrexate (TMQ, 2,4-diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl] quinazoline), a non-classical antifolate in methotrexate-resistant leukemia cells in vitro

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF043

21 January 2018

Leucovorin enhances cytotoxicity of trimetrexate/fluorouracil, but not methotrexate/fluorouracil, in CCRF-CEM cells

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF043

21 January 2018

Sequential trimetrexate, 5-fluorouracil and folinic acid are effective and well tolerated in metastatic colorectal carcinoma. The phase II study group of the AIO.

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF043

21 January 2018

The Functional Assessment of Cancer Therapy scale: development and validation of the general measure

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF043

21 January 2018

Trimetrexate as biochemical modulator of 5-fluorouracil/leucovorin in advanced colorectal cancer: final results of a randomised European study

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF043

21 January 2018

Integrated analysis of overall survival in two randomised studies comparing 5-fluorouracil/leucovorin with or without trimetrexate in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDF043

21 January 2018

Identifiers

10.1093/ANNONC/MDF043

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43894350&oldid=2104211999"